Tahara A

References (7)

Title : Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients - Tahara_2016_Curr.Vasc.Pharmacol_14_552
Author(s) : Tahara N , Yamagishi SI , Bekki M , Kodama N , Nakamura T , Sugiyama Y , Oshige T , Kumashiro Y , Honda A , Tahara A , Igata S , Fukumoto Y
Ref : Curr Vasc Pharmacol , 14 :552 , 2016
Abstract : Tahara_2016_Curr.Vasc.Pharmacol_14_552
ESTHER : Tahara_2016_Curr.Vasc.Pharmacol_14_552
PubMedSearch : Tahara_2016_Curr.Vasc.Pharmacol_14_552
PubMedID: 27357182

Title : Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice - Tahara_2009_Eur.J.Pharmacol_605_170
Author(s) : Tahara A , Matsuyama-Yokono A , Nakano R , Someya Y , Hayakawa M , Shibasaki M
Ref : European Journal of Pharmacology , 605 :170 , 2009
Abstract : Tahara_2009_Eur.J.Pharmacol_605_170
ESTHER : Tahara_2009_Eur.J.Pharmacol_605_170
PubMedSearch : Tahara_2009_Eur.J.Pharmacol_605_170
PubMedID: 19171131

Title : Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice - Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
Author(s) : Matsuyama-Yokono A , Tahara A , Nakano R , Someya Y , Hayakawa M , Shibasaki M
Ref : Naunyn Schmiedebergs Arch Pharmacol , 379 :191 , 2009
Abstract : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
ESTHER : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
PubMedSearch : Matsuyama-Yokono_2009_Naunyn.Schmiedebergs.Arch.Pharmacol_379_191
PubMedID: 18762913

Title : Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice - Matsuyama-Yokono_2009_Metabolism_58_379
Author(s) : Matsuyama-Yokono A , Tahara A , Nakano R , Someya Y , Shiraki K , Hayakawa M , Shibasaki M
Ref : Metabolism , 58 :379 , 2009
Abstract : Matsuyama-Yokono_2009_Metabolism_58_379
ESTHER : Matsuyama-Yokono_2009_Metabolism_58_379
PubMedSearch : Matsuyama-Yokono_2009_Metabolism_58_379
PubMedID: 19217455

Title : Evaluation of the antidiabetic effects of dipeptidyl peptidase-IV inhibitor ASP8497 in streptozotocin-nicotinamide-induced mildly diabetic mice - Tahara_2009_Pharmacology_83_177
Author(s) : Tahara A , Matsuyama-Yokono A , Nakano R , Someya Y , Hayakawa M , Shibasaki M
Ref : Pharmacology , 83 :177 , 2009
Abstract : Tahara_2009_Pharmacology_83_177
ESTHER : Tahara_2009_Pharmacology_83_177
PubMedSearch : Tahara_2009_Pharmacology_83_177
PubMedID: 19176982

Title : ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity - Matsuyama-Yokono_2008_Biochem.Pharmacol_76_98
Author(s) : Matsuyama-Yokono A , Tahara A , Nakano R , Someya Y , Nagase I , Hayakawa M , Shibasaki M
Ref : Biochemical Pharmacology , 76 :98 , 2008
Abstract : Matsuyama-Yokono_2008_Biochem.Pharmacol_76_98
ESTHER : Matsuyama-Yokono_2008_Biochem.Pharmacol_76_98
PubMedSearch : Matsuyama-Yokono_2008_Biochem.Pharmacol_76_98
PubMedID: 18468582

Title : Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo - Someya_2008_Naunyn.Schmiedebergs.Arch.Pharmacol_377_209
Author(s) : Someya Y , Tahara A , Nakano R , Matsuyama-Yokono A , Nagase I , Fukunaga Y , Takasu T , Hayakawa M , Shibasaki M
Ref : Naunyn Schmiedebergs Arch Pharmacol , 377 :209 , 2008
Abstract : Someya_2008_Naunyn.Schmiedebergs.Arch.Pharmacol_377_209
ESTHER : Someya_2008_Naunyn.Schmiedebergs.Arch.Pharmacol_377_209
PubMedSearch : Someya_2008_Naunyn.Schmiedebergs.Arch.Pharmacol_377_209
PubMedID: 18398600